Question 1

What is Immunome?

Accepted Answer

Immunome is a Company.

Question 2

How often does Immunome appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Immunome first tracked by Ergen?

Accepted Answer

First tracked on Jul 08, 2026.

Question 4

When was Immunome last mentioned in news?

Accepted Answer

Last active on Jul 08, 2026.

Question 5

What is Immunome's current news sentiment?

Accepted Answer

Aggregate sentiment score: 40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Immunome in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Immunome?

Accepted Answer

FDA accepts Immunome NDA for varegacestat (Jul 08, 2026, 6 articles).

Question 8

How did the "FDA accepts Immunome NDA for varegacestat" event impact Immunome?

Accepted Answer

Immunome is the sponsor of the NDA and stands to benefit if varegacestat is approved, potentially generating significant revenue from a novel oral therapy for desmoid tumors.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.